行业研究公司研究宏观策略财报招股书会议纪要 Token 低空经济十五五 AIGC 大模型

第5版，《流行病公报》世界卫生组织卫生紧急情况方案世界卫生组织东南亚区域办事处，2026年3月11日。报告期：2026年2月23日至3月8日

2026-03-12 世界卫生组织杨静🍦

核心事件与更新

公共卫生情报仪表盘发布：WHO 东南亚区域办事处（SEARO）推出公共卫生情报（PHI）仪表盘，提供重点传染病的常规流行病学更新和态势感知，涵盖流感、COVID-19、猴痘、登革热和尼帕病毒，网址：https://worldhealthorg.shinyapps.io/sear_phi/。
缅甸人道主义危机分析：发布《公共卫生态势分析——缅甸：冲突与人道主义危机》，总结健康状况、风险、系统需求及响应，指出冲突、自然灾害和经济崩溃加剧危机，超过半数人口受冲突影响，近70%卫生设施受损。
尼帕病毒风险评估：发布《尼帕病毒感染全球快速风险评估》，评估全球公共卫生风险为低，主要风险来自恩泽特地区蝙蝠溢出和旅行者传播，印度和孟加拉国为主要病例报告地区。
尼帕病毒问答：发布《尼帕病毒感染——印度西孟加拉邦（2026）——问答》，解答研讨会提出的关键问题，支持成员国和专业人士的准备工作。

流感

区域情况：2026年第8-10周，东南亚区域检测4310份样本，281例阳性，阳性率6%，主要为A(H3)亚型（54%），BVictoria谱系占23%。
国家分布：孟加拉国（A(H3)占99%）、泰国（A(H3)占60%）、印度（BVictoria占61%）、不丹（BVictoria占60%）、斯里兰卡（BVictoria占36%）。

COVID-19

区域趋势：2025年第1周至2026年第10周，孟加拉国、不丹、印度、缅甸、尼泊尔和泰国报告病例呈下降趋势，但数据不完整。
哨点监测：8个国家（孟加拉国、不丹、印度、马尔代夫、尼泊尔、斯里兰卡、泰国和东帝汶）2026年第10周检测病例数下降。

猴痘

区域累计病例：自2022年7月14日至2026年3月8日，东南亚区域报告1206例确诊病例（含15例死亡），其中33例为Ib谱系（印度18例、泰国14例、尼泊尔1例）。
最新病例：2026年第9-10周，印度报告1例新病例。

登革热

区域爆发：斯里兰卡（5724例）、印度（3019例）、东帝汶（2105例）、泰国（1288例），数据不完整的国家包括孟加拉国、不丹、马尔代夫、缅甸和尼泊尔。
国家趋势：
- 孟加拉国：2026年第10周报告71例新病例（较前周增4.4%），无死亡。
- 印度：2026年2月报告3019例（较1月降15%），全年累计6563例（较2025年同期降20%）。
- 东帝汶：2026年2月报告2105例（较1月增60%），为区域最大爆发。
- 斯里兰卡：2026年第8周报告1265例（较前周降15%），全年累计13760例。
- 泰国：2026年2月报告1288例（较1月降32%），全年累计3191例。

WHO Health Emergencies ProgrammeWHO Regional Office for South-East Asia5thedition(2026),11 March2026Reportingperiod:23Februaryto 08 March2026 Thisepidemiological bulletin aims to providethe situation of key infectiousdiseases intheWHOSouth-East AsiaRegionto inform risk assessmentsand responses. The bulletin usesinformation from publicly availablesources and New release: WHO South-East Asia Region Public Health Intelligence Dashboard.................................................2New publication: Public Health Situation Analysis–Myanmar: Conflict and humanitarian crisis..........................2New publication: Global Rapid Risk Assessment–Nipah virus infection................................................................3 Influenza............................................................................................................................................4Situation in the WHO South-East Asia Region..........................................................................................................4COVID-19............................................................................................................................................6Situation in the WHO South-East Asia Region..........................................................................................................6mpox..................................................................................................................................................8Situation in the WHO South-East Asia Region..........................................................................................................8Dengue.............................................................................................................................................10Situation in the WHO South-East Asia Region........................................................................................................10Bangladesh.............................................................................................................................................................11India........................................................................................................................................................................12Maldives..................................................................................................................................................................14Nepal.......................................................................................................................................................................14Sri Lanka..................................................................................................................................................................15Thailand..................................................................................................................................................................16 Key events and updates New release:WHO South-East Asia RegionPublic Health Intelligence Dashboard •WHO Health Emergencies Programme atWHO Regional Office forSouth-East Asia(SEARO)launchedthe Public Health Intelligence(PHI)Dashboard for the WHO South-East Asia Region, whichis now available online:https://worldhealthorg.shinyapps.io/sear_phi/•The dashboardaims to serve as the one stopsiteto provideroutine epidemiological updatesand situational awarenessonpriority diseases that pose threats to public health in the Region. New publication:Public Health Situation Analysis–Myanmar: Conflict and humanitarian crisis •On9 March 2026,the Public Health Situation Analysis(PHSA) waspublished, summarizing thehealth situation,health risks, health system needs, and humanitarian health response.•Myanmar’s humanitarian crisis continues to worsen due to conflict, natural disasters, and economic collapse.In early 2025, Myanmar ranked secondglobally for conflict intensity, with over half the population exposed to conflict. •Access to basic health services is severely limited in several conflict-affectedstates.Disease outbreaks are increasing due to unsafe water,poor sanitation, and disruptions to routine health services. New publication:Global Rapid Risk Assessment–Nipah virus infection •On 6 March 2026, the WHO Rapid Risk Assessment (RRA) on Nipah virusinfectionwas published. •The RRA evaluates the global public health risk posed by Nipah virus(NiV), taking into accountits epidemiology in enzootic countries withrecurrent zoonotic spillover and limited human-to-human transmission,as well as the risk in non-enzootic regions linked to infected travellers or •The RRA notes that Nipah virus remains geographically limited, with human cases reported mainly inBangladesh and India, and that although the virus has a high case-fatality ratio (40–75%), it has not •The report emphasizes that the outcomes of the WHO RRA are intended to promote transparency in the spiritof the International Health Regulations

点击免费查看完整报告